Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutations in dynamin 2 cause dominant centronuclear myopathy.

Marc Bitoun1, Svetlana Maugenre, Pierre-Yves Jeannet

  • 1INSERM U582, Institute of Myology, IFR14, Groupe Hospitalier Pitié-Salpêtrière, UPMC, 47 Boulevard de l'Hôpital, 75651 Paris Cedex 13, France.

Nature Genetics
|October 18, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Use of organ transplant solution to preserve skeletal muscle for cellular and spatial transcriptomic analyses.

Scientific reports·2026
Same author

Structural variant discovery and diagnostic impact in rare diseases from short-read and long-read sequencing.

medRxiv : the preprint server for health sciences·2026
Same author

AGRN-, LRP4-, MUSK-Related CMS: Clinical, Neurophysiological, Morphological, Genetic and Pathological Mechanisms.

Muscle & nerve·2026
Same author

Multimodal Sequencing and Reanalysis Approaches to End the Diagnostic Odyssey of Individuals with Suspected Rare Monogenic Diseases.

Genes·2026
Same author

Relative frequencies of muscle specific kinase antibody myasthenia in 46 centres worldwide.

Brain : a journal of neurology·2026
Same author

Early Clinical, Imaging, and Pathological Characteristics of SRPK3/TTN-Digenic Myopathy.

Annals of clinical and translational neurology·2026

Mutations in the dynamin 2 (DNM2) gene are linked to autosomal dominant centronuclear myopathy, a condition causing muscle weakness. These DNM2 gene mutations may disrupt centrosome function, leading to this rare congenital myopathy.

Area of Science:

  • Genetics
  • Cell Biology
  • Neuromuscular Disorders

Background:

  • Autosomal dominant centronuclear myopathy (ADCNM) is a rare congenital neuromuscular disorder.
  • It presents with delayed motor milestones and progressive muscle weakness.
  • The genetic basis for many ADCNM cases remains unclear.

Purpose of the Study:

  • To investigate the genetic cause of autosomal dominant centronuclear myopathy in affected families.
  • To identify specific gene mutations associated with the disease phenotype.
  • To elucidate the functional consequences of identified mutations on protein function and cellular processes.

Main Methods:

  • Genetic analysis of 11 families with autosomal dominant centronuclear myopathy.
  • Identification of recurrent and de novo missense mutations in the dynamin 2 (DNM2) gene.

Related Experiment Videos

  • Functional studies involving transfection of mutant DNM2 into cells to assess protein localization and function.

    • Main Results:

    • Recurrent and de novo missense mutations in the dynamin 2 (DNM2) gene were identified in 11 families with ADCNM.
    • DNM2 encodes a protein crucial for endocytosis, membrane trafficking, actin assembly, and centrosome cohesion.
    • Transfected mutant DNM2 proteins showed reduced labeling at the centrosome.

    Conclusions:

    • Mutations in the DNM2 gene are a significant cause of autosomal dominant centronuclear myopathy.
    • DNM2 mutations likely contribute to ADCNM pathogenesis by impairing centrosome function.
    • Further research into DNM2's role in muscle development and maintenance is warranted.